Prazotec

Lansoprazole

Duodenal ulcer. Cap: Benign gastric ulcer; esophageal reflux. Powd for inj: Gastric ulcer, acute stress ulcer & acute gastric mucosal lesion w/ bleeding, in patients unable to take oral formulation.

Cap Duodenal ulcer, esophageal reflux 1 cap daily for 4 wk. Benign gastric ulcer 1 cap daily for 8 wk. Powd for inj 30 mg by IV drip twice daily.

Cap: Should be taken on an empty stomach.

Powd for inj: Hypersensitivity. Concomitant administration w/ atazanavir sulfate.

Pregnancy & lactation. Cap: Maintenance therapy for treatment of patients w/ duodenal ulcer disease & pathological hypersecretory conditions including Zollinger-Ellison syndrome. Powd for inj: Not recommended for long-term use due to its high hemostatic effect. Patients w/ history of drug hypersensitivity; hepatic disorders. Min therapeutic necessity should be used according to disease condition. Patients w/ projectile or oozing bleeding or at risk for rapid bleeding eg, the case of presence of exposed blood vessels should undergo endoscopic hemostasis eg, heater probe or clipping. Administration of Prazotec may mask symptoms of gastric cancer. Rule out malignant nature of ulcer prior to initiation of therapy. Childn. Elderly.

Cap: Headache, diarrhea, asthenia, candidiasis, chest pain, edema, fever, flu syndrome, halitosis, infections, malaise. Powd for inj: Anaphylactic reactions eg, generalized rash, facial edema, dyspnea, shock; pancytopenia, agranulocytosis, hemolytic anemia, granulocytopenia, thrombocytopenia, anemia; severe hepatic dysfunction, jaundice, increased AST, ALT, lactic acid dehydrogenase, guanosine triphosphate; TEN (Lyell syndrome), oculomucocutaneous syndrome (SJS); interstitial pneumonia; interstitial nephritis.

Powd for inj: Gastric antisecretory effect of Prazotec may promote or inhibit absorption of concomitant drugs.

Antacids, Antireflux Agents & Antiulcerants

A02BC03 - lansoprazole ; Belongs to the class of proton pump inhibitors. Used in the treatment of peptic ulcer and gastro-oesophageal reflux disease (GERD).

K